Advertisement
Home Tags Cancer: Breast

Tag: Cancer: Breast

For patients with obesity

Bariatric Surgery in Obese Patients May Lower Cancer Risk

0
Among genetically predisposed, breast cancer rate higher in those who did not opt for bariatric surgery
Anticipated future shortages of oncology providers may have a serious and specific impact on women's health care

U.S. Oncologist Shortage May Impact Women’s Health

0
Major U.S. cities are expected to have a shortage of oncologists
For older patients with ductal carcinoma in situ who undergo breast-conserving surgery

No Benefit Seen for SLNB in BCS for DCIS in Older Women

0
Long-term outcomes similar with, without sentinel lymph node biopsy in breast-conserving surgery
The combination of anthracyclines and radiotherapy doses to treat childhood cancer is associated with an increased risk for subsequent breast cancer

Childhood Cancer Treatment Increases Risk for Breast Cancer Later

0
Additive risk seen between combined anthracyclines and radiotherapy doses to the breast
For each month of delay between diagnosis and surgery for ductal carcinoma in situ

Delay of Surgery for DCIS Ups Risk for Invasive Breast Cancer

0
Each month delay increases risk for invasive cancer by 1 percent
For women with primary breast cancer

Prediagnosis Exercise May Reduce CV Risk in Breast Cancer

0
Incidence of composite cardiovascular events decreased across increasing total MET hours/week
For patients with metastatic breast cancer

Patient Cost Responsibility Up for Guideline-Discordant Care

0
Guideline-discordant tx linked to $1,841 higher patient costs in first year in metastatic breast cancer
Unselected

Multigene Testing for All Breast Cancer Patients Cost-Effective

0
Findings support expansion of genetic testing to all women with breast cancer
Treatment of male breast cancer has evolved since 2004

Treatment of Male Breast Cancer Has Evolved From 2004 to 2014

0
Significant increases seen in total mastectomy, radiotherapy after breast conservation, endocrine tx
The addition of abemaciclib to fulvestrant provides a statistically significant and clinically meaningful gain in median overall survival

Drug Combo Extends Survival in Advanced Breast Cancer

0
Benefit seen for addition of CDK4/6 inhibitor after progression of disease on endocrine therapy